Skip to content
OpenCapital
Get started

Mativ Holdings MATV Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Tapes, labels & liners30%+3.4%
Filtration & netting25%0.0%
Paper & packaging17%+6.3%
Advanced films14%0.0%
Healthcare & other14%-12.5%

Other financials

Income statement

See full
Revenue$479.6M-1.1%
Gross profit$84.9M+16.9%
Operating income$7.3M+102%
Net income-$11.7M+97.3%
EPS (diluted)-$0.22+97.2%

Balance sheet

See full
Cash & equivalents$87.3M-6.9%
Total debt$1.1B-7.4%
Total equity$472.3M+10.3%
Total assets$2.0B-0.9%

Cash flow

See full
Operating cash flow$1.0M+106%
CapEx$8.4M-39.6%
Free cash flow-$7.4M+75.2%

Valuation

See full
Market cap$440.94M+25.1%
Enterprise value$1.45B+0.5%
P/S0.2×0.0×

Profitability

See full
Gross margin18.9%+1.0pp
Operating margin2.2%+1.1pp
Net margin-22.1%—
FCF margin5.9%+4.1pp

Returns & leverage

See full
Return on equity-68.5%—
Debt / equity2.3×-0.4×
Current ratio2.3×-0.1×